Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?

Is ZBH a bully banal to buy? We came crossed a bullish thesis on Zimmer Biomet Holdings, Inc. connected X.com by @MoneyShow. In this article, we volition summarize the bulls’ thesis connected ZBH. Zimmer Biomet Holdings, Inc.'s stock was trading astatine $87.27 arsenic of June 8^th. ZBH’s trailing and guardant P/E were 22.62 and 10.46 respectively according to Yahoo Finance.

ldutko/Shutterstock.com

Zimmer Biomet Holdings, Inc. (ZBH) is positioned arsenic a starring subordinate successful the planetary musculoskeletal healthcare market, with ascendant stock successful hep and genu replacements supported by a wide portfolio of orthopedic implants, surgical products, and enabling technologies. The institution continues to payment from favorable semipermanent manufacture trends, including aging populations, rising healthcare access, and increasing request for associated reconstruction procedures.

Read More: 15 AI Stocks That Are Quietly Making Investors Rich

Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential

ZBH has further strengthened its competitory presumption done expanding surgeon adoption of its cementless implant systems and the ROSA robotic-assisted country platform, which is helping amended surgical precision and workflow ratio portion deepening lawsuit relationships. The institution is besides expanding into faster-growing categories specified arsenic precocious extremities, ft and ankle, and craniomaxillofacial solutions, broadening its addressable marketplace beyond accepted associated reconstruction.

Its integration of Paragon 28 enhances vulnerability to the charismatic ft and ankle segment, portion improvement of Monogram’s mBos semi-autonomous robotic exertion could further reenforce its enactment successful next-generation orthopedic procedures. Although concerns person emerged astir GLP-1 value nonaccomplishment drugs perchance reducing aboriginal associated replacement demand, Zimmer believes structural demographic trends and accrued process accessibility should proceed driving semipermanent growth.

Financially, the institution generates beardown currency travel that supports disciplined superior allocation, acquisitions, and ongoing stock repurchases. Despite its marketplace leadership, recurring gross profile, and expanding robotics ecosystem, ZBH trades adjacent 12 times earnings, materially beneath its humanities valuation person to 20 times earnings, suggesting meaningful upside imaginable arsenic execution improves and investors progressively admit the durability of its semipermanent maturation trajectory.

Previously, we covered a bullish thesis connected Zimmer Biomet Holdings, Inc. (ZBH) by QuestforYield successful March 2025, which highlighted the company’s enactment successful orthopedic implants, robotics adoption, and beardown escaped currency travel generation. ZBH’s banal terms has depreciated by astir 16.07% since our coverage. @MoneyShow shares a akin presumption but emphasizes connected enlargement into higher-growth orthopedic categories and next-generation robotic technologies.